Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Grant or award Chief Scientific Officer acquired 66,500 shares (grant or award)
  2. 4 Open-market sale Director sold 110,933 shares at an average $29.50 ($3,273,008)
  3. 4 Open-market sale Director sold 16,500 shares at $28.73 ($474,045)
  4. 4 Open-market sale Director sold 782 shares at $33.10 ($25,884)
  5. 4 Planned sale SVP, Head of Finance & Admin. sold 2,735 shares at $28.20 ($77,127)
  6. 4 Planned sale Chief Scientific Officer sold 2,856 shares at $28.20 ($80,539)
  7. 4 Planned sale Director sold 19,732 shares at an average $34.14 ($673,748)
  8. 4 Planned sale Director sold 13,535 shares at an average $35.16 ($475,879)
  9. 4 Planned sale Director sold 36,684 shares at an average $35.29 ($1,294,437)
  10. 4 Planned sale Director sold 5,441 shares at $35.13 ($191,142)
  11. 4 Planned sale Director sold 29,941 shares at an average $35.32 ($1,057,460)
  12. 4 Planned sale Director sold 30,974 shares at an average $35.50 ($1,099,697)
  13. 4 Planned sale Director sold 3,617 shares at an average $35.14 ($127,102)
  14. 4 Planned sale Director sold 120,242 shares at an average $36.07 ($4,336,893)
  15. 4 Planned sale Director sold 80,293 shares at an average $36.15 ($2,902,720)
  16. 4 Planned sale Chief Operating Officer sold 8,976 shares at $34.41 ($308,864)
  17. 4 Planned sale SVP, Head of Finance & Admin. sold 1,390 shares at $34.55 ($48,025)
  18. 4 Planned sale Chief Scientific Officer sold 2,339 shares at $34.55 ($80,812)
  19. 4 Planned sale Director sold 4,592 shares at an average $35.10 ($161,198)
  20. 4 Planned sale Chief Scientific Officer sold 2,161 shares at $31.89 ($68,914)

Page 6 of 19 · 361 filings